(A) PCA3 and PRUNE2 expression in nonneoplastic prostatic glandular tissue and in prostatic adenocarcinoma in the TCGA cohort illustrating consistent gene expression differences between tumor (n=497) and nonneoplastic (n=52) prostate in both cohorts. The gene discussed is PRUNE2; the disease is prostate adenocarcinoma.